Takenari Gotanda

762 total citations
16 papers, 581 citations indexed

About

Takenari Gotanda is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Takenari Gotanda has authored 16 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Takenari Gotanda's work include Drug Transport and Resistance Mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Takenari Gotanda is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Takenari Gotanda collaborates with scholars based in Japan, United States and South Korea. Takenari Gotanda's co-authors include Masayuki Nakagawa, Hideki Enokida, Kenryu Nishiyama, Misako Haraguchi, Tatsuhiko Furukawa, Tokushi Tachiwada, Tomoyuki Sumizawa, Naohiko Seki, Kazumori Kawakami and Hiroyuki Kubo and has published in prestigious journals such as Blood, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Takenari Gotanda

16 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takenari Gotanda Japan 13 404 212 142 88 54 16 581
Nobuyasu Hayashi Japan 11 283 0.7× 107 0.5× 188 1.3× 144 1.6× 78 1.4× 29 565
Fujun Zhao China 14 442 1.1× 243 1.1× 97 0.7× 70 0.8× 153 2.8× 38 683
Miaofeng Zhang China 9 421 1.0× 144 0.7× 155 1.1× 71 0.8× 61 1.1× 13 613
A.M. Merino Spain 11 255 0.6× 270 1.3× 272 1.9× 69 0.8× 86 1.6× 14 589
Takanori Nishimori Japan 12 308 0.8× 71 0.3× 123 0.9× 79 0.9× 54 1.0× 30 490
Zhenghui Guo China 13 359 0.9× 239 1.1× 101 0.7× 165 1.9× 128 2.4× 34 661
Gabriela Nestal de Moraes Brazil 14 614 1.5× 145 0.7× 184 1.3× 40 0.5× 61 1.1× 32 827
Hellen Kuasne Brazil 14 323 0.8× 107 0.5× 157 1.1× 111 1.3× 72 1.3× 24 615
Meiheng Yang United States 10 339 0.8× 60 0.3× 129 0.9× 21 0.2× 38 0.7× 18 503
Qianghua Hu United States 17 485 1.2× 105 0.5× 208 1.5× 30 0.3× 123 2.3× 22 734

Countries citing papers authored by Takenari Gotanda

Since Specialization
Citations

This map shows the geographic impact of Takenari Gotanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takenari Gotanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takenari Gotanda more than expected).

Fields of papers citing papers by Takenari Gotanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takenari Gotanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takenari Gotanda. The network helps show where Takenari Gotanda may publish in the future.

Co-authorship network of co-authors of Takenari Gotanda

This figure shows the co-authorship network connecting the top 25 collaborators of Takenari Gotanda. A scholar is included among the top collaborators of Takenari Gotanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takenari Gotanda. Takenari Gotanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nishimura, Hiroaki, Yasutoshi Yamada, Satoshi Hisano, et al.. (2018). Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report. BMC Nephrology. 19(1). 254–254. 1 indexed citations
2.
Tatarano, Shuichi, Takeshi Chiyomaru, Kazumori Kawakami, et al.. (2011). Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines. International Journal of Oncology. 40(4). 951–959. 51 indexed citations
3.
Kawakami, Kazumori, Hideki Enokida, Takeshi Chiyomaru, et al.. (2011). The functional significance of miR-1 and miR-133a in renal cell carcinoma. European Journal of Cancer. 48(6). 827–836. 117 indexed citations
4.
Tachiwada, Tokushi, Zhe‐Sheng Chen, Xiaofang Che, et al.. (2007). Isolation and characterization of arsenite-resistant human epidermoid carcinoma KB cells. Oncology Reports. 18(3). 721–7. 7 indexed citations
5.
Haraguchi, Misako, Takenari Gotanda, Tokushi Tachiwada, et al.. (2006). Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5′-DFUR cytotoxicity. Cancer Letters. 244(2). 239–246. 7 indexed citations
6.
Jeung, Hei‐Cheul, Misako Haraguchi, Tatsuhiko Furukawa, et al.. (2006). Protection against DNA damage‐induced apoptosis by the angiogenic factor thymidine phosphorylase. FEBS Letters. 580(5). 1294–1302. 28 indexed citations
7.
Che, Xiaofang, Chunlei Zheng, Masato Mutoh, et al.. (2006). Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines. Blood. 107(12). 4880–4887. 36 indexed citations
8.
Sumizawa, Tomoyuki, Misako Haraguchi, Takenari Gotanda, et al.. (2006). Direct activation of the human major vault protein gene by DNA-damaging agents. Oncology Reports. 15(3). 645–52. 28 indexed citations
9.
Gotanda, Takenari, Misako Haraguchi, Tokushi Tachiwada, et al.. (2006). Molecular basis for the involvement of thymidine phosphorylase in cancer invasion. International Journal of Molecular Medicine. 17(6). 1085–91. 12 indexed citations
10.
Kawakami, Kazumori, Hideki Enokida, Tokushi Tachiwada, et al.. (2006). Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncology Reports. 16(3). 521–31. 48 indexed citations
11.
Kawamoto, Ken, Hideki Enokida, Takenari Gotanda, et al.. (2005). p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Biochemical and Biophysical Research Communications. 339(3). 790–796. 74 indexed citations
12.
Zheng, Chunlei, Tomoyuki Sumizawa, Xiaofang Che, et al.. (2004). Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. Biochemical and Biophysical Research Communications. 326(1). 100–107. 24 indexed citations
13.
Nakajima, Yuichi, Takenari Gotanda, Tatsuhiko Furukawa, et al.. (2004). Inhibition of Metastasis of Tumor Cells Overexpressing Thymidine Phosphorylase by 2-Deoxy-l-Ribose. Cancer Research. 64(5). 1794–1801. 53 indexed citations
14.
Enokida, Hideki, Takenari Gotanda, Hiroyuki Kubo, et al.. (2002). Reversal of P‐Glycoprotein‐mediated Paclitaxel Resistance by New Synthetic Isoprenoids in Human Bladder Cancer Cell Line. Japanese Journal of Cancer Research. 93(9). 1037–1046. 30 indexed citations
15.
Furukawa, Tatsuhiko, Masahiro Okamoto, Yuichi Nakajima, et al.. (2002). Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.. PubMed. 62(10). 2834–9. 45 indexed citations
16.
Gotanda, Takenari, et al.. (2001). Endoscopic treatment of a long fibroepithelial ureteral polyp. International Journal of Urology. 8(8). 467–469. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026